3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
4
Prostatic Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Breast Neoplasms
3
Advanced Solid Tumor
3
Pancreatic Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Hypoxia
2
Advanced Solid Tumors
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pelvic Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mesothelioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Interventions
Capecitabine
35
Oxaliplatin
32
Fluorouracil
29
Leucovorin
26
Irinotecan
22
Bevacizumab
19
Cetuximab
17
Radiotherapy
16
Radiation
11
Surgical Procedures, Operative
6
Radiotherapy, Intensity-Modulated
5
Gene Expression Profiling
5
Chemotherapy, Adjuvant
5
Celecoxib
5
Neoadjuvant Therapy
4
Immunohistochemistry
4
Biopsy
4
Amplified Fragment Length Polymorphism Analysis
4
cediranib
3
Reverse Transcriptase Polymerase Chain Reaction
3
Receptor Protein-Tyrosine Kinases
3
Folfox protocol
3
Drug Therapy
3
Cisplatin
3
sargramostim
2
regorafenib
2
pembrolizumab
2
fludarabine phosphate
2
aldesleukin
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Rectal Neoplasms
×
Injections
×
Clear all
NCT02584400
2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2
Terminated
1 enrolled